N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide

C28H35BrN6O2S — CID 10304142

IUPACN-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide
SMILESCOc1cc2c(N3CCN(C(=S)NCc4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCCCC1
InChIInChI=1S/C28H35BrN6O2S/c1-36-25-17-23-24(18-26(25)37-16-15-33-9-3-2-4-10-33)31-20-32-27(23)34-11-13-35(14-12-34)28(38)30-19-21-5-7-22(29)8-6-21/h5-8,17-18,20H,2-4,9-16,19H2,1H3,(H,30,38)
InChIKeyHGMKSBWNBCRURE-UHFFFAOYSA-N
MW599.60 g/mol
LogP4.46
Rot. Bonds8

About N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide

N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide (PubChem CID 10304142) has the molecular formula C28H35BrN6O2S and a molecular weight of 599.60 g/mol. Its IUPAC name is N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide.

Molecular Properties

Compound NameN-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide
PubChem CID10304142
Molecular FormulaC28H35BrN6O2S
Molecular Weight599.60 g/mol
Exact Mass598.17
IUPAC NameN-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide
SMILESCOc1cc2c(N3CCN(C(=S)NCc4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCCCC1
InChIInChI=1S/C28H35BrN6O2S/c1-36-25-17-23-24(18-26(25)37-16-15-33-9-3-2-4-10-33)31-20-32-27(23)34-11-13-35(14-12-34)28(38)30-19-21-5-7-22(29)8-6-21/h5-8,17-18,20H,2-4,9-16,19H2,1H3,(H,30,38)
InChIKeyHGMKSBWNBCRURE-UHFFFAOYSA-N
XLogP4.46
TPSA65.99 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500599.60
LogP ≤ 54.46
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide?
The IUPAC name of N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide (CID 10304142) is N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide.
What is the SMILES notation for N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide?
The canonical SMILES for N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide is COc1cc2c(N3CCN(C(=S)NCc4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCCCC1.
What is the InChIKey of N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide?
The InChIKey is HGMKSBWNBCRURE-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H35BrN6O2S/c1-36-25-17-23-24(18-26(25)37-16-15-33-9-3-2-4-10-33)31-20-32-27(23)34-11-13-35(14-12-34)28(38)30-19-21-5-7-22(29)8-6-21/h5-8,17-18,20H,2-4,9-16,19H2,1H3,(H,30,38).
What are the key properties of N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide?
N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide has a molecular weight of 599.60 g/mol, XLogP of 4.46, 8 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-bromophenyl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide is sourced from PubChem (CID 10304142), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).